IC Memo Generator

IC Memos

AI-generated investment committee memos with analyst oversight

Argenx SE (ARGX) - Investment Update
Dec 8, 2024AI + Analyst Review
Final

Vyvgart CIDP data exceeds expectations. Recommend increasing position by 2%.

BuyAutoimmunePhase 3
Revolution Medicines (RVMD) - Risk Assessment
Dec 5, 2024AI Generated
Draft

Trial delay detected. Evaluating impact on thesis. Maintain position pending enrollment update.

HoldOncologyDelay Risk
Moderna (MRNA) - Quarterly Review
Dec 1, 2024AI + Analyst Review
Final

Insider selling pattern warrants attention. RSV and flu pipeline on track.

MonitormRNAInsider Activity
Ionis Pharmaceuticals (IONS) - Catalyst Preview
Nov 28, 2024AI + Analyst Review
Final

FDA AdCom for Donidalorsen scheduled. High probability of approval.

BuyRNA TherapeuticsFDA Catalyst